Alzheimer’s, disappointment new drugs: anti-amyloid monoclonals damage the brain
A new blow to research against Alzheimer's. The much-acclaimed anti-amyloid antibodies, including the more popular lecanemab, which was granted accelerated...
A new blow to research against Alzheimer's. The much-acclaimed anti-amyloid antibodies, including the more popular lecanemab, which was granted accelerated...